HOW UCLA STEM CELL RESEARCH IS TRANSFORMING MEDICINE
EXPLORE OUR IMPACT

Newsroom

A biomimetic microparticle designed to recruit and reactivate CAR-iNKT cells, helping sustain cancer-fighting activity.
Image of Dr. Lili Yang (left) and Dr. Sanaz Memarzadeh (right) standing in a science laboratory.
Microscopy image of blood vessels (red) in a mouse glioma tumor after CAR-T cell treatment. Yellow shows areas with good blood flow, highlighted using tomato lectin, a protein that marks vessels.
From left to right: Dr. Noah Federman, Dr. Robert Damoiseaux and Dr. David Ulmert stand outside on the UCLA campus.
T cells attacking a tumor cell in a solid cancer, illustrating immune response and T cell exhaustion in cancer immunotherapy.
A rendering of the UCLA Research Park lobby
UCLA scientist Dr. Lili Yang stands beside her lab members.
Dr. Antoni Ribas with three members of his research team at UCLA
Green fluorescent tumor cells in brain organoid under microscope
Microscopic blood smear showing normal red blood cells and several large purple-stained lymphoblasts characteristic of B-lymphoblastic leukemia